CV
CapsoVision, IncCompany Information
- Company Name
- CapsoVision, Inc
- CIK
- CIK0001378325
- Category
- <br>Emerging growth company
- Ticker: Exchange
- CV: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3845
- SIC Description
- Electromedical & Electrotherapeutic Apparatus
- Ticker
- CV
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-09-18
- Last sale
- 2026-06-08
- Shares purchased (TTM)
- 2,792,421
- Shares sold (TTM)
- 1,200
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 5,145,665
- Shares outstanding
- 49,937,525
- Ownership
- 10.30%
Earnings Market Reaction
- Filing date
- 2026-08-13
- Price on filing date
- —
- 1-month reaction
- -11.78%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
| Series A Preferred Stock | - | - | - | - | 18 | ||||||
Assets Current | |||||||||||
| Series B Preferred Stock | - | - | - | - | 6 | ||||||
| Series C Preferred Stock | - | - | - | - | 6 | ||||||
| Series C1 Preferred Stock | - | - | - | - | 4 | ||||||
| Series D Preferred Stock | - | - | - | - | 2 | ||||||
| Series D1 Preferred Stock | - | - | - | - | 7 | ||||||
| Series D2 Preferred Stock | - | - | - | - | 11 | ||||||
| Series E Preferred Stock | - | - | - | - | 14 | ||||||
| Series F1 Preferred Stock | - | - | - | - | 13 | ||||||
| Series F2 Preferred Stock | - | - | - | - | 12 | ||||||
| Series G Preferred Stock | - | - | - | - | 6 | ||||||
| Series G1 Preferred Stock | - | - | - | - | 7 | ||||||
| Cash Equivalents At Carrying Value | 9 | 18 | 10 | 18 | 1 | ||||||
| Accounts Receivable Net Current | 2 | 2 | 2 | 2 | 2 | ||||||
| Inventory Net | 5 | 3 | 3 | 3 | 3 | ||||||
| Prepaid Expense And Other Assets Current | 1 | 1 | 1 | 1 | 2 | ||||||
| Assets Current | 17 | 25 | 17 | 24 | 8 | ||||||
| Property Plant And Equipment Net | 1 | 1 | 1 | 1 | 1 | ||||||
| Operating Lease Right Of Use Asset | 1 | 1 | 1 | 1 | 1 | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 19 | 26 | 18 | 26 | 10 | ||||||
Liabilities And Stockholders Equity | |||||||||||
| Series H Preferred Stock | - | - | - | - | 48 | ||||||
Liabilities Current | |||||||||||
| Accounts Payable Current | 0 | 1 | 1 | 1 | 1 | ||||||
| Accrued Liabilities Current | 4 | 3 | 3 | 3 | 2 | ||||||
| Contract With Customer Liability Current | 0 | 0 | 0 | 0 | 0 | ||||||
| Short Term Non Bank Loans And Notes Payable | - | - | - | - | 1 | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities Current | 5 | 5 | 4 | 5 | 4 | ||||||
| Operating Lease Liability Noncurrent | 0 | 0 | 0 | 1 | 1 | ||||||
| Liabilities | 5 | 6 | 5 | 5 | 5 | ||||||
Temporary Equity | |||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | - | 0 | 0 | 0 | 144 | ||||||
| Preferred Stock Value | 0 | - | - | - | - | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 183 | 183 | 169 | 169 | 1 | ||||||
| Retained Earnings Accumulated Deficit | -170 | -163 | -156 | -148 | -140 | ||||||
| Stockholders Equity | 13 | 20 | 13 | 20 | -139 | ||||||
| Liabilities And Stockholders Equity | 19 | 26 | 18 | 26 | 10 | ||||||
| Temporary Equity Par Or Stated Value Per Share | - | - | 0.00 | - | - | ||||||
| Temporary Equity Shares Authorized | - | - | 0 | 0 | - | ||||||
| Temporary Equity Shares Issued | - | - | 0 | 0 | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 300 | 300 | 300 | 300 | 190 | ||||||
| Common Stock Shares Issued | 50 | 50 | 47 | 47 | 2 | ||||||
| Shares Outstanding | 50 | 50 | 47 | 47 | 2 | ||||||
| Temporary Equity Shares Outstanding | - | 0 | 0 | 0 | 39 | ||||||
| Temporary Equity Liquidation Preference | - | - | 0 | 0 | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | - | - | - | - | ||||||
| Preferred Stock Shares Authorized | 10 | - | - | - | - | ||||||
| Preferred Stock Shares Issued | 0 | - | - | - | - | ||||||
| Preferred Stock Shares Outstanding | 0 | - | - | - | - | ||||||
Select a line item above to chart it.
Recent filings
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialCapsoVision, Inc (CV) — SEC Financial Statements & Analysis
CapsoVision, Inc (CV) is a electromedical & electrotherapeutic apparatus company, incorporated in DE. CapsoVision, Inc trades on Nasdaq as: CV. CapsoVision, Inc (CV)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, CapsoVision, Inc carries a market cap of $378.53M, a P/E ratio of -10.75x, a P/B ratio of 28.75x, a P/S ratio of 22.70x, an enterprise value of $369.45M, and an EV/EBITDA multiple of -10.48x. On profitability, it posts a gross margin of 51.35%, an operating margin of -213.13%, a net margin of -211.13%, a Return on Equity (ROE) of 55.96%, a Return on Assets (ROA) of -250.42%, and a Return on Invested Capital (ROIC) of -1247.51%. Per share, it reports EPS of $-0.70, diluted EPS of $-0.70, free cash flow per share of $-0.56, and a dividend per share of $0.00. On the balance sheet, it maintains a current ratio of 3.35x, a quick ratio of 2.20x, working capital of $12.12M, a debt-to-equity ratio of 0.41x, a debt ratio of 0.29, free cash flow of $-27.89M (TTM), and net debt of $-9.08M. Figures sourced from SEC EDGAR.
- Market Cap
- $378.53M
- P/E TTM
- -10.75x
- EPS TTM
- $-0.70
- P/B TTM
- 28.75x
- ROE TTM
- 55.96%
- ROA TTM
- -250.42%
- Debt To Equity
- 0.41x
- Free Cash Flow TTM
- $-27.89M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is CapsoVision, Inc in?
CapsoVision, Inc (CV) operates in the Electromedical & Electrotherapeutic Apparatus industry.
What exchange does CV trade on?
CapsoVision, Inc (CV) trades on the Nasdaq.
Where is CapsoVision, Inc incorporated?
CapsoVision, Inc is incorporated in DE.
When was CapsoVision, Inc (CV)'s most recent SEC filing?
CapsoVision, Inc (CV)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13.
What is CV's market cap?
CapsoVision, Inc (CV) has a market capitalization of $378.53M as of 2026-06-30.
What is CV's EPS (earnings per share)?
CapsoVision, Inc (CV)'s trailing twelve month EPS is $-0.70 as of 2026-06-30.
What is CV's ROE (return on equity)?
CapsoVision, Inc (CV)'s trailing twelve month Return on Equity (ROE) is 55.96% as of 2026-06-30.
What is CV's ROA (return on assets)?
CapsoVision, Inc (CV)'s trailing twelve month Return on Assets (ROA) is -250.42% as of 2026-06-30.
What is CV's ROIC (return on invested capital)?
CapsoVision, Inc (CV)'s trailing twelve month Return on Invested Capital (ROIC) is -1247.51% as of 2026-03-31.
What is CV's EV/EBITDA?
CapsoVision, Inc (CV)'s trailing twelve month EV/EBITDA is -10.48x as of 2026-06-30.